Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets
Abstract Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS), and it remains the most common immune-mediated disorder affecting the CNS. While the cause of MS is unclear, the underlying pathomechanisms are thought to be either destruction by autoimmune T cells or d...
Main Authors: | Vaidya Govindarajan, Juan Pablo de Rivero Vaccari, Robert W. Keane |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | Journal of Neuroinflammation |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12974-020-01944-9 |
Similar Items
-
Inflammasome Proteins As Biomarkers of Multiple Sclerosis
by: Robert W. Keane, et al.
Published: (2018-03-01) -
Role of NLRP3 inflammasome in systemic sclerosis
by: Cong Lin, et al.
Published: (2022-08-01) -
The Role of Non-canonical and Canonical Inflammasomes in Inflammaging
by: Brianna Cyr, et al.
Published: (2022-02-01) -
The Inflammasome in Times of COVID-19
by: Juan Carlos de Rivero Vaccari, et al.
Published: (2020-10-01) -
Inflammasome signaling proteins as biomarkers of COVID-19
by: Roey Hadad, et al.
Published: (2023-04-01)